SIM
SNDX icon

Spark Investment Management’s Syndax Pharmaceuticals SNDX Stock Holding History

Spark Investment Management’s Portfolio SNDX Stock Details SNDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-12,400
Closed -$55K – 712
2018
Q4 		$55K Buy
+12,400
New +$68K ﹤0.01% 599
2018
Q3 		– Sell
-28,300
Closed -$198K – 729
2018
Q2 		$198K Buy
+28,300
New +$278K 0.01% 560

Other funds holding SNDX

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Spark Investment Management's SNDX Position: Q1 2019 in Review

Spark Investment Management sold out of Syndax Pharmaceuticals (SNDX) in Q1 2019, closing a stake of 12,400 shares — an estimated $55K sold.

Spark Investment Management first reported a position in SNDX in Q2 2018 and held it in 2 quarters. The position peaked at $198K in Q2 2018. 69 funds tracked by Wall St. Rank hold SNDX as of Q1 2019.

  • Spark Investment Management reported no remaining Syndax Pharmaceuticals position as of Q1 2019 after selling out during the quarter.
  • Spark Investment Management sold 12,400 Syndax Pharmaceuticals shares in Q1 2019, an estimated $55K.
  • Spark Investment Management first reported a position in Syndax Pharmaceuticals in Q2 2018 and held it in 2 quarters.
  • Spark Investment Management's Syndax Pharmaceuticals position peaked at $198K in Q2 2018.
  • 69 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q1 2019.

Based on Spark Investment Management's 13F filing for Q1 2019, filed 7 May 2019.